Stanford University
Showing 121-140 of 1,585 Results
-
Vasyl Rakivnenko
AI Technical Lead, IT & Legal Design Lab, Information Systems
BioVasyl Rakivnenko is the AI Technical Lead at Stanford Law School’s Legal Design Lab, where he develops and applies AI systems to expand access to justice. A technology entrepreneur and applied AI researcher, he has led AI initiatives across startups, venture firms, and public companies.
He collaborates with Stanford faculty on research at the intersection of AI, economics, and decision-making, and has presented his work at Stanford GSB, UNLV, and more.
Vasyl holds a Bachelor’s in Business Administration from the University of Mondragon, an MBA from Kozminski University, and is a graduate of the Stanford Executive Program. -
Lindsey Ralls
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioLindsey Ralls, MD, is a Clinical Associate Professor in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University. She is originally from California, and after undergraduate training at Stanford University she completed her medical degree and internship at Baylor College of Medicine in Houston, TX. She then returned to the Bay Area and completed her Anesthesia residency (2008) and Obstetric Anesthesia fellowship (2009) at Stanford University.
-
Nilam Ram
Professor of Communication and of Psychology
BioNilam Ram studies the dynamic interplay of psychological and media processes and how they change from moment-to-moment and across the life span.
Nilam’s research grows out of a history of studying change. After completing his undergraduate study of economics, he worked as a currency trader, frantically tracking and trying to predict the movement of world markets as they jerked up, down and sideways. Later, he moved on to the study of human movement, kinesiology, and eventually psychological processes - with a specialization in longitudinal research methodology. Generally, Nilam studies how short-term changes (e.g., processes such as learning, information processing, emotion regulation, etc.) develop across the life span, and how longitudinal study designs contribute to generation of new knowledge. Current projects include examinations of age-related change in children’s self- and emotion-regulation; patterns in minute-to-minute and day-to-day progression of adolescents’ and adults’ emotions; and change in contextual influences on well-being during old age. He is developing a variety of study paradigms that use recent developments in data science and the intensive data streams arriving from social media, mobile sensors, and smartphones to study change at multiple time scales. -
Asheen Rama
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Asheen Rama is a member of the Division of Pediatric Anesthesiology. He regularly organizes and conducts medical simulations across various hospital units, utilizing both traditional in-situ methods and advanced immersive technologies, such as virtual and augmented reality. He also collaborates with the Stanford CHARIOT program, leading efforts to integrate immersive technologies into medical education and working to scale these innovations nationally and internationally.
Dr. Rama teaches a diverse range of learners, including medical students, residents, fellows, and nurses. His academic interests focus on simulation, medical education, and artificial intelligence. Additionally, he has a strong interest in the medical humanities and has taught several Stanford undergraduate and medical student courses that explore the intersection of art and medicine. -
Sneha Ramakrishna
Assistant Professor of Pediatrics (Hematology/Oncology)
BioSneha Ramakrishna obtained her B. A. from the University of Chicago and her M.D. from the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. In medical school, through the Howard Hughes Medical Research Scholar Award, she joined Dr. Crystal Mackall’s laboratory, where she designed and developed various GD2 CAR-Ts and tested them in preclinical models. During her residency training in Pediatrics at the Children’s Hospital of Philadelphia, she cared for some of the first patients treated with CD19 CAR T cells, learning the power of this therapy first-hand. During her fellowship in Pediatric Hematology/Oncology at the Johns Hopkins/National Cancer Institute combined program, she worked with Dr. Terry Fry. She evaluated the mechanism of CD22 CAR T cell relapse in patients by developing an antigen escape model and establishing a deeper understanding of the effects of antigen density on CAR-T phenotype, expansion, and persistence (Fry…Ramakrishna…Mackall Nat Med, 2018; Ramakrishna, et al., Clinical Cancer Research, 2019). Since arriving at Stanford, Dr. Ramakrishna leads an interdisciplinary team that designs, develops, and successfully implements a robust correlative science platform for our novel CAR-T therapies. Analyzing patient samples from our first-in-human GD2 CAR-T trial (NCT04196413) treating a universally fatal cancer, diffuse midline glioma (DMG), we identified that intracerebroventricular CAR-T administration correlates with enhanced pro-inflammatory cytokines and reduced immunosuppressive cell populations in cerebrospinal fluid as compared to intravenous CAR-T administration (Majzner*, Ramakrishna*, et al., Nature 2022 *co-first authors). Her research program evaluates unique sets of patient samples using novel single-cell immune profiling to identify the drivers of CAR-T success or failure. Building on these findings, her team assesses approaches to enhance CAR-T efficacy and translate these findings to the clinic.
Clinically, Dr. Ramakrishna cares for children with solid tumors and treats hematologic, solid, and brain tumor pediatric patients with CAR T cell therapies in the Cancer Cellular Therapies program.
